New drug K9 tested for thyroid eye disease – early results show promise
NCT ID NCT06467435
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This early study tested a new drug called K9 in a small group of people with thyroid eye disease (TED). The main goal was to check safety and how the drug works in the body. Participants took K9 twice a day for up to 24 weeks, and researchers tracked side effects and changes in dry eye symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kentucky
Lexington, Kentucky, 40506, United States
Conditions
Explore the condition pages connected to this study.